https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-08 / Clin. Immunol. 2008 Dec;129(3):482-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-08 / Clin. Immunol. 2008 Dec;129(3):482-912008-10-08 00:00:002019-02-15 09:19:18Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-02 / Cell. Immunol. 2009;254(2):135-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-02 / Cell. Immunol. 2009;254(2):135-412008-10-02 00:00:002019-02-15 09:02:59The anti-tumor effect of human monocyte-derived dendritic cells loaded with HSV-TK/GCV induced dying cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-01 / J. Immunother. 2008 Oct;31(8):771-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-01 / J. Immunother. 2008 Oct;31(8):771-802008-10-01 00:00:002019-02-15 09:16:52Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-322008-10-01 00:00:002021-11-15 17:03:44Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-27 / Surg. Today 2008;38(10):911-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-27 / Surg. Today 2008;38(10):911-202008-09-27 00:00:002008-09-27 00:00:00Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-22 / Blood 2009 Jan;113(1):18-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-22 / Blood 2009 Jan;113(1):18-272008-09-22 00:00:002019-02-15 09:25:29Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-672008-09-20 00:00:002019-02-15 08:45:28The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-19 / Immunity 2008 Sep;29(3):372-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-19 / Immunity 2008 Sep;29(3):372-832008-09-19 00:00:002019-02-15 08:44:33Cancer immunotherapy by dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-19 / J. Dermatol. Sci. 2009 Jan;53(1):40-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-19 / J. Dermatol. Sci. 2009 Jan;53(1):40-72008-09-19 00:00:002019-02-15 09:19:14Immunohistological analysis of peptide-induced delayed-type hypersensitivity in advanced melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-15 / J Transl Med 2008 Sep;6:51
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-15 / J Transl Med 2008 Sep;6:512008-09-15 00:00:002019-02-15 09:11:46In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
